Delaware General Assembly

Passed 1/30/20

The General Assembly has ended, the current status is the final status.

HB 263 w/ HA 1

1/29/20

Bentz

Reps. Bennett, Minor-Brown

This Amendment revises House Bill No. 263 by doing all of the following: 1. Requires at least 1 formulation of each type of prescription insulin be on the lowest tier of the drug formulary. 2. Defines the "lowest tier of the drug formulary" as the lowest tier for generic drugs, if the insulin is a generic and the lowest tier for brand-name drugs, if the insulin is brand-name. 3. Clarifies that the $100 per month cost-sharing cap includes deductible payments and cost-sharing amounts charged once a deductible is met. 4. Corrects the date for the applicability of this Act so it includes insurance plans that begin on January 1, 2021. 5. Clarifies that the cap on the copay applies to covered individuals who are in compliance with the coordination of benefits policies under the State employee insurance plans. 6. Corrects a typographical error.

View HTML View PDF